Valcare Medical Transcatheter Annuloplasty Patent
Summary
Valcare Medical, Inc. has published patent application US20260108352A1 for a transcatheter annuloplasty system and methods for treating valvular regurgitation. The application, filed October 20, 2025, covers an annuloplasty device with anterior and posterior anchors that transition from a constrained state to a deployed state, extending through windows into tissue at the native valve site. The system is designed for catheter-based delivery to manipulate the annuloplasty device within a patient's heart using a delivery handle to selectively deploy anchors while closing the anterior-to-posterior distance of the valve.
“Systems and methods are provided for an annuloplasty device and delivery system for treating valvular regurgitation.”
About this source
GovPing monitors USPTO Patent Applications - Prosthetics (A61F) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 222 changes logged to date.
What changed
Valcare Medical, Inc. published US patent application US20260108352A1 for a transcatheter annuloplasty system designed to treat valvular regurgitation through a catheter-delivered ring with deployable anchors. The application covers the device structure including anterior and posterior anchors that transition from constrained to deployed states, as well as the delivery handle mechanism for selective anchor deployment. Competitors developing transcatheter valvular repair technologies should monitor this filing for potential freedom-to-operate considerations or licensing opportunities.
Archived snapshot
Apr 24, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
TRANSCATHETER ANNULOPLASTY SYSTEM AND METHODS
Application US20260108352A1 Kind: A1 Apr 23, 2026
Assignee
Valcare Medical, Inc.
Inventors
Nadav YELLIN, Yoav ROZEN, Yuri FALKOVICH
Abstract
Systems and methods are provided for an annuloplasty device and delivery system for treating valvular regurgitation. The annuloplasty device (e.g., a transcatheter annuloplasty ring) may include a tube having anterior and posterior anchors that may transition from a constrained state within the tube to a deployed state in which anchors extend through windows of the tube into tissue at the native valve site. Each anchor may include valvular and atrial anchors as well as anchors having different shapes (e.g., a curved anchor and a non-curved anchor). The annuloplasty device may be delivered to the native valve site via a catheter and the annuloplasty device may be manipulated within the patient's heart using a delivery handle to selectively deploy anchors while closing the anterior-to-posterior distance of the valve to treat valvular regurgitation.
CPC Classifications
A61F 2/2448 A61F 2/2466 A61F 2220/0016 A61F 2230/0065
Filing Date
2025-10-20
Application No.
19363425
Mentioned entities
Parties
Related changes
Get daily alerts for USPTO Patent Applications - Prosthetics (A61F)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Prosthetics (A61F) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.